LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.21 | 21.74 | 1 | 6235 | 0.0002 | -0.3142 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.21 | 21.74 | 658 | 6235 | 0.1055 | 0.5185 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.18 | 21.74 | 125 | 6114 | 0.0204 | 0.2399 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.18 | 21.74 | 715 | 6114 | 0.1169 | 0.5363 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.18 | 21.74 | 2 | 6114 | 0.0003 | -0.2542 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 76.18 | 21.74 | 639 | 6114 | 0.1045 | 0.5152 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.15 | 21.74 | 98 | 6167 | 0.0159 | 0.2030 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.15 | 21.74 | 705 | 6167 | 0.1143 | 0.5326 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.15 | 21.74 | 2 | 6167 | 0.0003 | -0.2538 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.15 | 21.74 | 610 | 6167 | 0.0989 | 0.5056 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.12 | 21.74 | 57 | 6211 | 0.0092 | 0.1254 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.12 | 21.74 | 696 | 6211 | 0.1121 | 0.5294 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.12 | 21.74 | 3 | 6211 | 0.0005 | -0.2155 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.12 | 21.74 | 564 | 6211 | 0.0908 | 0.4905 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.09 | 21.74 | 51 | 6201 | 0.0082 | 0.1102 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.09 | 21.74 | 690 | 6201 | 0.1113 | 0.5279 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.09 | 21.74 | 1 | 6201 | 0.0002 | -0.3144 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.09 | 21.74 | 548 | 6201 | 0.0884 | 0.4854 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.06 | 21.74 | 34 | 6152 | 0.0055 | 0.0564 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.06 | 21.74 | 695 | 6152 | 0.1130 | 0.5302 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.06 | 21.74 | 1 | 6152 | 0.0002 | -0.3148 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.06 | 21.74 | 533 | 6152 | 0.0866 | 0.4812 | MN20160310_N01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.03 | 21.74 | 38 | 6155 | 0.0062 | 0.0710 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.03 | 21.74 | 692 | 6155 | 0.1124 | 0.5293 | MN20160310_N01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.03 | 21.74 | 2 | 6155 | 0.0003 | -0.2539 | MN20160310_N01 | K20 |